Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for Rapid Micro Biosystems (RPID) over the last 5 years, with Q3 2025 value amounting to $7000.0.

  • Rapid Micro Biosystems' Asset Writedowns and Impairment changed N/A to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $448000.0, marking a year-over-year increase of 37157.89%. This contributed to the annual value of $95000.0 for FY2024, which is 17941.18% up from last year.
  • Per Rapid Micro Biosystems' latest filing, its Asset Writedowns and Impairment stood at $7000.0 for Q3 2025.
  • In the past 5 years, Rapid Micro Biosystems' Asset Writedowns and Impairment ranged from a high of $235000.0 in Q1 2025 and a low of $6000.0 during Q3 2021
  • In the last 5 years, Rapid Micro Biosystems' Asset Writedowns and Impairment had a median value of $49000.0 in 2022 and averaged $84090.9.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 273333.33% in 2022, then soared by 15000.0% in 2024.
  • Over the past 5 years, Rapid Micro Biosystems' Asset Writedowns and Impairment (Quarter) stood at $16000.0 in 2021, then surged by 568.75% to $107000.0 in 2022, then crashed by 68.22% to $34000.0 in 2023, then tumbled by 70.59% to $10000.0 in 2024, then dropped by 30.0% to $7000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $7000.0 for Q3 2025, versus $206000.0 for Q2 2025 and $235000.0 for Q1 2025.